Creating Benefits from Omega-3 Functional Foods and Nutraceuticals


Foods currently eaten by Americans have abundant amounts of essential omega-6 (n-6) nutrients and relatively few omega-3 (n-3) nutrients. The average omega 3 - 6 balance score of typical US foods is about 6. This imbalance causes the average American to accumulate tissue proportions of n-3 and n-6 highly unsaturated fatty acids (HUFA) with about 77% n-6 in HUFA. This HUFA balance links to many chronic health conditions that are made worse by overabundant actions of food-based omega-6 HUFA. Americans currently spend more on treating food-based health conditions than they spend on food. Less medication is needed to treat signs and symptoms when a key dietary cause of the signs and symptoms is prevented. Informed food producers can readily prepare and market new food products with more n-3 and less n-6 nutrients to reverse the current national nutrient imbalance and help people attain and maintain a healthy HUFA balance. New functional foods and nutraceuticals will help consumers shift their financial resources from treating signs and symptoms caused by HUFA imbalance to preventing the nutrient imbalance that causes the need to treat.

Share and Cite:

Clark, C. and Lands, B. (2015) Creating Benefits from Omega-3 Functional Foods and Nutraceuticals. Food and Nutrition Sciences, 6, 1613-1623. doi: 10.4236/fns.2015.617166.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] (2015) Relating Diets to Tissue HUFA.
[2] Lands, B. and Lamoreaux, E. (2012) Using 3-6 Differences in Essential Fatty Acids Rather than 3/6 Ratios Gives Useful Food Balance Scores. Nutrition & Metabolism, 9, No. 46.
[3] Lands, B. (2011) Prevent the Cause, Not Just the Symptoms. Prostaglandins & Other Lipid Mediators, 96, 90-93.
[4] Lands, B. (2014) Historical Perspectives on the Impact of n-3 and n-6 Nutrients on Health. Progress in Lipid Research, 55, 17-29.
[5] Lands, B. (2015) Omega-3 PUFAs Lower the Propensity for Arachidonic Acid Cascade Overreactions. Biomed Research International, 2015, Article ID 285135.
[6] Lands, B. (2016) Fatty Acids: Essential Fatty Acids. In: Caballero, B., Finglas, P. and Toldrá, F., Eds., The Encyclopedia of Food and Health, Academic Press, Oxford, Vol. 2, 615-622.
[7] Ameur, A., Enroth, S., Johansson, A., Zaboli, G., Igl, W., Johansson, A.C.V., Rivas, M.A., Daly, M.J., Schmitz, G., Hicks, A.A., Meitinger, T., Feuk, L., van Duijn, C., Oostra, B., Pramstaller, P.P., Rudan, I., Wright, A.F., Wilson, J.F., Campbell, H. and Gyllensten, A. (2012) Genetic Adaptation of Fatty-Acid Metabolism: A Human-Specific Haplotype Increasing the Biosynthesis of Long-Chain Omega-3 and Omega-6 Fatty Acids. The American Journal of Human Genetics, 90, 809-820.
[8] Centers for Disease Control and Prevention (CDC) (2015) Minority Health.
[9] Clark, C. and Lands, B. (2016) What Financial Motivations Support Preventive Nutrition? Nutrition and Health, Unpublished.
[10] Centers for Disease Control and Prevention (2015) Chronic Disease Overview.
[11] Gerteis, J., Izrael, D., Deitz, D., LeRoy, L., Ricciardi, R., Miller, T. and Basu, J., Agency for Healthcare Research and Quality (AHRQ) (2014) Multiple Chronic Conditions Chartbook.
[12] Health Spending Explorer (2015) Peterson-Kaiser Health System Tracker.
[13] Keehan, S.P., Cuckler, G.A., Sisko, A.M., Madison, A.J., Smith, S.D., Stone, D.A., Poisal, J.A., Wolfe, C.J. and Lizonitz, J.M. (2015) National Health Expenditure Projections, 2014-24: Spending Growth Faster than Recent Trends. Health Affairs, 8, 1707-1717. (Exhibit 3)
[14] Kaiser Family Foundation (2012) Health Care Costs: A Primer. (Figure 1)
[15] Fries, J.F., Koop, C.E., Sokolov, J., Beadle, C.E. and Wright, D. (1998) Beyond Health Promotion: Reducing Need and Demand for Medical Care. Health Affairs, 17, 70-84.
[16] Centers for Disease Control and Prevention (CDC) (2009) The Power of Prevention Chronic Disease . . . the Public Health Challenge of the 21st Century.
[17] Hibbeln, J.R. and Davis, J.M. (2009) Considerations Regarding Neuropsychiatric Nutritional Requirements for Intakes of Mmega-3 Highly Unsaturated Fatty Acids. Prostaglandins, Leukotrienes and Essential Fatty Acids, 81, 179-186.
[18] Centers for Disease Control and Prevention (CDC) (2015) Chronic Obstructive Pulmonary Disease.
[19] Lands, B. (2016) Omega-3 Fatty Acids Counterbalance Actions of Omega-6 Fatty Acids. In: Raatz, S. and Bibus, D., Eds., Fish and Fish Oils in Health and Disease, Elsevier, Philadelphia
[20] Murphy, R.C., Pickett, W.C., Culp, B.R and Lands, W.E.M. (1981) Tetraene and Pentaene Leukotrienes: Selective Production from Murine Mastocytoma Cells after Dietary Manipulation. Prostaglandins, 22, 613-622.
[21] Soderstrom, M., Mannervik, B., Garkov, V. and Hammarstrom, S. (1992) On the Nature of Leukotriene C4 Synthase in Human Platelets. Archives of Biochemistry and Biophysics, 294, 70-74.
[22] Lee, T.H., Sethi, T., Crea, A.E.G., Peters, W., Arm, J.P., Horton, C.E., Walport, M.J. and Spur, B.W. (1988) Characterization of Leukotriene B3: Comparison of its Biological Activities with Leukotriene B4 and Leukotriene B5 in Complement Receptor Enhancement, Lysozyme Release and Chemotaxis of Human Neutrophils. Clinical Science, 74, 467-475.
[23] Mohanan, S., Horibata, S., McElwee, J.L., Dannenberg, A.J. and Coonrod, S.A. (2013) Identification of Macrophage Extracellular Trap-like Structures in Mammary Gland Adipose Tissue: a Preliminary Study. Frontiers in Immunology, 4, 1-8.
[24] Li, P., Oh, D.Y., Bandyopadhyay, G., Lagakos, W.S., Talukdar, S., Osborn, O., Johnson, A., Chung, H., Mayoral, R., Maris, M., Ofrecio, J.M., Taguchi, S., Lu, M. and Olefsky, J.M. (2015) LTB4 Promotes Insulin Resistance in Obese Mice by Acting on Macrophages, Hepatocytes and Myocytes. Nature Medicine, 21, 239-247.
[25] Spite, M., Hellmann, J., Tang, Y., Mathis, S.P., Kosuri, M., Bhatnagar, A., Jala, V.R. and Haribabu, B. (2011) Deficiency of the Leukotriene B4 Receptor, BLT-1, Protects against Systemic Insulin Resistance in Diet-induced Obesity. The Journal of Immunology, 187, 1942-1949.
[26] Alvheim, A.R., Malde, M.K., Osei-Hyiaman, D., Lin, Y.H., Pawlosky, R.L., Madsen, L., Kristiansen, K., Frøyland, L. and Hibbeln, J.R. (2012) Dietary Linoleic Acid Elevates Endocannabinoids 2-AG and Anandamide and Induces Obesity. Obesity, 10, 1984-1994.
[27] Alvheim A.R., Torstensen B.E., Lin Y.H., Lillefosse H.H., Lock E.J., Madsen L., Frøyland L., Hibbeln J.R. and Malde M.K. (2014) Dietary Linoleic Acid Elevates the Endocannabinoids 2-AG and Anandamide and Promotes Weight Gain in Mice Fed a Low Fat Diet. Lipids, 49, 59-69.
[28] Alvheim, A.R., Torstensen, B.E., Lin, Y.H., Lillefosse, H.H., Lock, E.J., Madsen, L., Hibbeln, J.R. and Malde, M.K. (2013) Dietary Linoleic Acid Elevates Endogenous 2-Arachidonoylglycerol and Anandamide in Atlantic Salmon (Salmo salar L.) and Mice, and Induces Weight Gain and Inflammation in Mice. British Journal of Nutrition, 109, 1508-1517.
[29] The Look AHEAD Research Group, Wing, R.R., Bolin, P., Brancati, F.L., Bray, G.A., Clark, J.M., Coday, M., Crow, R.S., Curtis, J.M., Egan, C.M., Espeland, M.A., Evans, M., Foreyt, J.P., Ghazarian, S., Gregg, E.W., Harrison, B., Hazuda, H.P., Hill, J.O., Horton, E.S., Hubbard, V.S., Jakicic, J.M., Jeffery, R.W., Johnson, K.C., Kahn, S.E., Kitabchi, A.E., Knowler, W.C., Lewis, C.E., Maschak-Carey, B.J., Montez, M.G., Murillo, A., Nathan, D.M., Patricio, J., Peters, A., Pi-Sunyer, X., Pownall, H., Reboussin, D., Regensteiner, J.G., Rickman, A.D., Ryan, D.H., Safford, M., Wadden, T.A., Wagenknecht, L.E., West, D.S., Williamson, D.F. and Yanovski, S.Z. (2013) Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes. The New England Journal of Medicine, 369, 145-154.
[30] Lands, W.E.M. (2003) Diets Could Prevent Many Diseases. Lipids, 38, 317-321.
[31] Marugame, T. and Mizuno, S. (2005) Comparison of Prostate Cancer Mortality in Five Countries: France, Italy, Japan, UK and USA from the WHO Mortality Database (1960-2000). Japanese Journal of Clinical Oncology, 35, 690-691.
[32] Howlader, N., Noone, A.M., Krapcho, M., Garshell, J., Miller, D., Altekruse, S.F., Kosary, C.L., Yu, M., Ruhl, J., Tatalovich, Z., Mariotto, A., Lewis, D.R., Chen, H.S., Feuer, E.J. and Cronin, K.A., Eds. (2015) Prostate Cancer: Cancer Statistics Review, 1975-2012, National Cancer Institute.
[33] Huang, R.Y., Li, S.S., Guo, H.Z., Huang, Y., Zhang, X., Li, M.Y., Chen, G.G. and Zeng, X. (2014) Thromboxane A2 Exerts Promoting Effects on Cell Proliferation Through Mediating Cyclooxygenase-2 Signal in Lung Adenocarcinoma Cells. Journal of Cancer Research and Clinical Oncology, 140, 375-386.
[34] Ramsden, C.E., Faurot, K.R., Zamora, D., Suchindran, C.M., MacIntosh, B.A., Gaylord, S., Ringel, A., Hibbeln, J.R., Feldstein, A.E., Mori, T.A., Barden, A., Lynch, C., Coble, R., Mas, E., Palsson, O., Barrow, D.A. and Mann, J.D. (2013) Targeted Alteration of Dietary n-3 and n-6 Fatty Acids for the Treatment of Chronic Headaches: A Randomized Trial. Pain, 154, 2441-2451.
[35] (2015) Omega 3-6 Apps Use Balance Scores.
[36] Bibus, D. and Lands, B. (2015) Balancing Proportions of Competing Omega-3 and Omega-6 Highly Unsaturated Fatty Acids (HUFA) in Tissue Lipids. Prostaglandins LeukotEssent Fatty Acids, 99, 19-23.
[37] Ramsden, C.E., Faurot, K.R., Zamora, D., Palsson, O.S., MacIntosh, B.A., Gaylord, S., Taha, A.Y., Rapoport, S.I., Hibbeln, J.R., Davis, J.M. and Mann, J,D. (2015) Targeted Alterations in Dietary n-3 and n-6 Fatty Acids Improve Life Functioning and Reduce Psychological Distress among Patients with Chronic Headache: A Secondary Analysis of a Randomized Trial. Pain, 156, 587-596.
[38] MacIntosh, B.A., Ramsden, C.E., Faurot, K.R., Zamora, D., Mangan, M., Hibbeln, J.R. and Mann, J.D. (2013) Low-n-6 and Low-n-6 Plus High-n-3 Diets for Use in Clinical Research. British Journal of Nutrition, 110, 559-568.
[39] Wood, K.E., Mantzioris, E., Gibson, R.A. and Muhlhausler, B.S. (2013) Incorporating Macadamia Oil and Butter to Reduce Dietary Omega-6 Polyunsaturated Fatty Acid Intake. Nutrition & Dietetics, 70, 94-100.
[40] U.S. Department of Defense (2013) Defense Science Board Study on Technology Innovation Enablers for Superiority in 2030. 80-83.
[41] Marriott, B.P., Yu, K., Majchrzak-Hong, S., Johnson, J. and Hibbeln, J.R. (2014) Understanding Diet and Modeling Changes in the Omega-3 and Omega-6 Fatty Acid Composition of U.S. Garrison Foods for Active Duty Personnel. Military Medicine, 179, 168-175.
[42] Lin, Y.H., Hanson, J.A., Strandjord, S.E., Salem, N.M., Dretsch, M.N., Haub, M.D. and Hibbeln, J.R. (2014) Fast Transmethylation of Total Lipids in Dried Blood by Microwave Irradiation and Its Application to a Population Study. Lipids, 49, 839-851.
[43] DuPont Pioneer (2015) Plenish® High Oleic Soybeans
[44] Branch, W.D. (2014) Registration of “Georgia-13M” Peanut. Journal of Plant Registrations, 8, 253-256.
[45] Gorbet, D. (2003) SunOleic®/High Oleic Peanuts: A Step Forward.
[46] Isleib, T.G., Pattee, H.E., Sanders, T.H., Hendrix, K.W. and Dean, L.O. (2006) Compositional and Sensory Comparisons between Normal- and High-Oleic Peanuts. Journal of Agricultural and Food Chemistry, 54, 1759-1763.
[47] Derbyshire, E.J. (2014) A Review of the Nutritional Composition, Organoleptic Characteristics and Biological Effects of the High Oleic Peanut. International Journal of Food Sciences and Nutrition, 65, 781-790.
[48] Haytowitz, D.B. (2012) List of Key Foods Based on NHANES 2007-08.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.